ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,498, issued on April 29, was assigned to NANOMEDTRIX LLC (Coralville, Iowa).
"Pharmaceutical composition with nanoparticle-based drug delivery combined with non-invasive radiographic monitoring model" was invented by Joe G Assouline (Coralville, Iowa) and Sean K. Sweeney (Coralville, Iowa).
According to the abstract* released by the U.S. Patent & Trademark Office: "A mesoporous silica nanoparticle ("MSN"); a bioactive agent loaded into the MSN and an enteric coating encapsulating the surface of the MSN for oral administration or combination with more than one other pharmaceutical composition each having distinct bioactive agents."
The patent was filed on Aug. 21, 2024, under Appl...